Pessary use improves sexual function in pelvic organ prolapse.
"Sexually active women who are affected by pelvic floor disorder may expect improvement in sexual function with pessary use," Dr. Husam Abed said at the annual meeting of the Society of Gynecologic Surgeons.
Dr. Abed and his colleagues in the department of obstetrics and gynecology at the University of New Mexico, Albuquerque, performed a subanalysis of data from 80 women who had been fitted successfully with pessaries for the treatment of prolapse and/or urinary incontinence between September 2004 and January 2006.
The women completed the 12-item Intimate Relationship Scale (IRS) before pessary placement and again at 6-12 months after placement. Scores range from 12 to 60, with higher scores indicating better sexual function.
Complete follow-up data were available for 64 women. Of these, 32 were sexually active at follow-up--21 who continued pessary use and 11 who discontinued use.
There were essentially no differences between the two groups in terms of demographics or clinical variables.
Women who continued pessary use had a significantly greater mean change in IRS scores--a 9-point increase, compared with a 2-point increase for those who discontinued pessary use, Dr. Abed reported at the meeting jointly sponsored by the American College of Surgeons.
Both groups had comparable IRS scores at baseline--a mean score of 32 for those who continued pessary use and of 35 for those who did not.
Likewise, both groups had improvements in sexual function at follow-up--a mean score of 41 for those who continued pessary use and of 37 for those who did not.
Desire for intercourse in women who continued pessary use increased 50%, compared with no increase among women who did not continue use.
Similarly, satisfaction from sexual intercourse increased 48% in women who continued pessary use, while women who did not continue use had no increase in sexual satisfaction.
Interestingly, there was no change in the frequency of sexual activity in either group.
Dr. Abed stated that he had no relevant financial relationships to disclose.
BY KERRI WACHTER
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Women's Health|
|Publication:||Internal Medicine News|
|Date:||Nov 15, 2008|
|Previous Article:||Sexual side effects 'silent issue' in cancer care: sexual impact is little explored in women with gynecologic cancers, although 100% will be affected.|
|Next Article:||Best practices in: chronic inflammatory demyelinating polyradiculoneuropathy in the internal medicine setting.|